158 related articles for article (PubMed ID: 37169960)
1. Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins.
Wang Y; Liu W; Xu Y; He X; Yuan Q; Luo P; Fan W; Zhu J; Zhang X; Cheng X; Jiang Y; Xu HE; Zhuang Y
Nat Chem Biol; 2023 Nov; 19(11):1351-1360. PubMed ID: 37169960
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors.
Yadav MK; Maharana J; Yadav R; Saha S; Sarma P; Soni C; Singh V; Saha S; Ganguly M; Li XX; Mohapatra S; Mishra S; Khant HA; Chami M; Woodruff TM; Banerjee R; Shukla AK; Gati C
Cell; 2023 Oct; 186(22):4956-4973.e21. PubMed ID: 37852260
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.
Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J
J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage.
Bode M; Herrnstadt GR; Dreher L; Ehnert N; Kirkerup P; Lindenmeyer MT; Meyer-Schwesinger CF; Ehmke H; Köhl J; Huber TB; Krebs CF; Steinmetz OM; Wiech T; Wenzel UO
Hypertension; 2024 Jan; 81(1):138-150. PubMed ID: 37909169
[TBL] [Abstract][Full Text] [Related]
7. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
[TBL] [Abstract][Full Text] [Related]
8. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
Li XX; Clark RJ; Woodruff TM
Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
[TBL] [Abstract][Full Text] [Related]
9. Decoding anaphylatoxins: unveiling the molecular mechanisms of complement receptor activation and signaling.
Fernández FJ; Vega MC
Trends Biochem Sci; 2024 Apr; 49(4):280-282. PubMed ID: 38233283
[TBL] [Abstract][Full Text] [Related]
10. Role of complement anaphylatoxin receptors in a mouse model of acute burn-induced pain.
Morgan M; Deuis JR; Woodruff TM; Lewis RJ; Vetter I
Mol Immunol; 2018 Feb; 94():68-74. PubMed ID: 29274925
[TBL] [Abstract][Full Text] [Related]
11. C3aR and C5aR1 act as key regulators of human and mouse β-cell function.
Atanes P; Ruz-Maldonado I; Pingitore A; Hawkes R; Liu B; Zhao M; Huang GC; Persaud SJ; Amisten S
Cell Mol Life Sci; 2018 Feb; 75(4):715-726. PubMed ID: 28921001
[TBL] [Abstract][Full Text] [Related]
12. The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist.
Li XX; Kumar V; Clark RJ; Lee JD; Woodruff TM
Front Pharmacol; 2020; 11():591398. PubMed ID: 33551801
[TBL] [Abstract][Full Text] [Related]
13. Anaphylatoxin Receptors C3aR and C5aR1 Are Important Factors That Influence the Impact of Ethanol on the Adipose Secretome.
McCullough RL; McMullen MR; Poulsen KL; Kim A; Medof ME; Nagy LE
Front Immunol; 2018; 9():2133. PubMed ID: 30294325
[No Abstract] [Full Text] [Related]
14. Anaphylatoxins and their corresponding receptors as potential drivers in cartilage calcification during osteoarthritis progression.
Ruths L; Huber-Lang M; Schulze-Tanzil G; Riegger J
Osteoarthritis Cartilage; 2024 May; 32(5):514-525. PubMed ID: 38242312
[TBL] [Abstract][Full Text] [Related]
15. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
[TBL] [Abstract][Full Text] [Related]
16. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
[TBL] [Abstract][Full Text] [Related]
17. Anaphylatoxins spark the flame in early autoimmunity.
Schanzenbacher J; Köhl J; Karsten CM
Front Immunol; 2022; 13():958392. PubMed ID: 35958588
[TBL] [Abstract][Full Text] [Related]
18. IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.
Orrem HL; Nilsson PH; Pischke SE; Kleveland O; Yndestad A; Ekholt K; Damås JK; Espevik T; Bendz B; Halvorsen B; Gregersen I; Wiseth R; Andersen GØ; Ueland T; Gullestad L; Aukrust P; Barratt-Due A; Mollnes TE
Front Immunol; 2018; 9():2035. PubMed ID: 30258440
[No Abstract] [Full Text] [Related]
19. The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics.
Ghosh M; Rana S
Int Immunopharmacol; 2023 May; 118():110081. PubMed ID: 36989901
[TBL] [Abstract][Full Text] [Related]
20. The complement C3a and C5a signaling in renal diseases: a bridge between acute and chronic inflammation.
Buelli S; Imberti B; Morigi M
Nephron; 2024 Mar; ():. PubMed ID: 38452744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
